Abilify and Rebound effect - a phase IV clinical study of FDA data
Summary:
Rebound effect is reported as a side effect among people who take Abilify (aripiprazole), especially for people who are male, 40-49 old, have been taking the drug for 10+ years also take Effexor, and have Schizoid personality disorder.
The phase IV clinical study analyzes which people have Rebound effect when taking Abilify. It is created by eHealthMe based on reports of 97,308 people who have side effects when taking Abilify from the FDA, and is updated regularly.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,451 Abilify users. Check the latest studies of Abilify.
What is Rebound effect?
Rebound effect (take-back effect) is found to be associated with 371 drugs and 567 conditions by eHealthMe. Check the latest studies of Rebound effect.
97,308 people reported to have side effects when taking Abilify.
Among them, 16 people (0.02%) have Rebound effect.
Among these 16 people:
How long have people been on Abilify when they have Rebound effect? *
What is the gender of people who have Rebound effect when taking Abilify? *
What is the age of people who have Rebound effect when taking Abilify? *
What are other drugs people take besides Abilify? *
What are other side effects people have besides Rebound effect? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Abilify and have Rebound effect?
- Check whether Rebound effect is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Abilify:
- Abilify (101,451 reports)
Rebound effect treatments and more:
- Rebound effect (8,859 reports)
How severe was Rebound effect and when was it recovered:
Expand to all the drugs that have ingredients of aripiprazole:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Abilify:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Rebound effect:
- Rebound effect (371 drugs)
Browse all the conditions that are associated with Rebound effect:
- Rebound effect (567 conditions)
Related publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Abdominal Pain in Sulfatrim Pediatric, how severe and when it was recovered? - now
- Could Fluticasone Propionate cause Fluid Retention? - 9 seconds ago
- Drug interactions of Tegretol and Covera-Hs - 10 seconds ago
- Could Isoniazid cause Interstitial Nephritis? - 13 seconds ago
- Could Isoniazid cause Nephritis - Interstitial? - 14 seconds ago
- Could Cyclophosphamide cause Macular Hole? - 55 seconds ago
- Could Nitroglycerin cause Orthostatic Hypotension? - a minute ago
- Drug interactions of Fluoxetine and Minoxidil - a minute ago
- Drug interactions of Novolog and Garlic - a minute ago
- Could Ranolazine cause Ventricular Fibrillation? - a minute ago